LIVER TRANSPLANT; COMPLICATIONS
Clinical trials for LIVER TRANSPLANT; COMPLICATIONS explained in plain language.
Never miss a new study
Get alerted when new LIVER TRANSPLANT; COMPLICATIONS trials appear
Sign up with your email to follow new studies for LIVER TRANSPLANT; COMPLICATIONS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can pre- and Post-Transplant exercise boost liver patient outcomes?
Disease control ENROLLING_BY_INVITATIONThis study tests whether a structured exercise program before and after liver transplant helps patients recover faster and have fewer complications. Sixty adults awaiting a liver transplant will take part. The program includes supervised training before surgery and continued exer…
Matched conditions: LIVER TRANSPLANT; COMPLICATIONS
Phase: NA • Sponsor: Maria dels Angels Cebria i Iranzo, PT, PhD • Aim: Disease control
Last updated May 26, 2026 08:41 UTC
-
Can a diabetes drug help liver transplant patients control blood sugar and weight?
Disease control ENROLLING_BY_INVITATIONThis study compares two diabetes medications, semaglutide and sitagliptin, in 58 adults who have received a liver transplant and have poorly controlled diabetes. The goal is to see which drug better improves blood sugar control and reduces body weight. Participants will take one …
Matched conditions: LIVER TRANSPLANT; COMPLICATIONS
Phase: PHASE4 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated May 26, 2026 08:31 UTC
-
Sedative drug may shield liver transplant patients from organ damage
Disease control OngoingThis study tests whether giving a sedative called dexmedetomidine during liver transplant surgery can protect the new liver and other organs from damage. Researchers will measure a substance in the blood that shows how well the blood vessel lining is protected. The study involves…
Matched conditions: LIVER TRANSPLANT; COMPLICATIONS
Phase: PHASE4 • Sponsor: Assiut University • Aim: Disease control
Last updated May 26, 2026 08:30 UTC
-
New drug may reduce need for blood pressure meds during liver transplants
Disease control OngoingThis study tests if a drug called Angiotensin II can help control blood pressure during liver transplant surgery, reducing the need for other blood pressure medications. It involves 50 adults with severe liver disease who are receiving a liver from a deceased donor. The goal is t…
Matched conditions: LIVER TRANSPLANT; COMPLICATIONS
Phase: PHASE2, PHASE3 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
Liver transplant drug may shield kidneys from harm
Prevention ENROLLING_BY_INVITATIONThis study tests whether giving a drug called angiotensin 2 during liver transplant surgery can prevent acute kidney injury, a common and serious complication. About 30 adults with end-stage liver disease will be randomly assigned to receive either the drug plus standard care, or…
Matched conditions: LIVER TRANSPLANT; COMPLICATIONS
Phase: PHASE4 • Sponsor: University of California, Los Angeles • Aim: Prevention
Last updated May 20, 2026 11:53 UTC